Turner PR - Search Results

1

Low-density lipoprotein metabolism in rats treated with cyclosporine.

López-Miranda J, Vilella E, Pérez-Jiménez F, Espino A, Jiménez-Perepérez JA, Masana L, Turner PR. López-Miranda J, et al. Among authors: turner pr. Metabolism. 1993 Jun;42(6):678-83. doi: 10.1016/0026-0495(93)90232-d. Metabolism. 1993. PMID: 8510510

2

Low density lipoprotein metabolism in rats with puromycin aminonucleoside-induced nephrotic syndrome.

Joven J, Masana L, Villabona C, Vilella E, Bargalló T, Trias M, Figueras M, Turner PR. Joven J, et al. Among authors: turner pr. Metabolism. 1989 May;38(5):491-5. doi: 10.1016/0026-0495(89)90204-7. Metabolism. 1989. PMID: 2725289

3

Low density lipoprotein ligand-receptor interactions in normal healthy individuals characterized by their XbaI apolipoprotein B DNA polymorphism.

Vilella E, Balanyà J, Masana L, Marsal S, La Ville AE, Turner PR. Vilella E, et al. Among authors: turner pr. Atherosclerosis. 1992 Mar;93(1-2):145-53. doi: 10.1016/0021-9150(92)90208-x. Atherosclerosis. 1992. PMID: 1350724

4

Treatment of diet-resistant polygenic hypercholesterolaemic patients with a new nicotinate derivative; in vivo and in vitro low density lipoprotein metabolic studies.

Masana L, Escobar A, Joven J, Solá R, Vilella E, Bargallo T, Turner PR. Masana L, et al. Among authors: turner pr. J Clin Pharmacol. 1989 Mar;29(3):201-6. doi: 10.1002/j.1552-4604.1989.tb03313.x. J Clin Pharmacol. 1989. PMID: 2723106

5

Interaction of oxidized low density lipoproteins with both apo B,E and scavenger receptors. A model for its production in vitro.

Vilella E, Joven J, Bargalló T, Turner PR, Masana L. Vilella E, et al. Among authors: turner pr. Clin Chim Acta. 1992 Sep 15;210(1-2):93-108. doi: 10.1016/0009-8981(92)90048-u. Clin Chim Acta. 1992. PMID: 1330377

6

Concentrations of lipids and apolipoproteins in patients with clinically well-controlled insulin-dependent and non-insulin-dependent diabetes.

Joven J, Vilella E, Costa B, Turner PR, Richart C, Masana L. Joven J, et al. Among authors: turner pr. Clin Chem. 1989 May;35(5):813-6. Clin Chem. 1989. PMID: 2720975

7

Limitations of the Friedewald formula for estimating low-density lipoprotein cholesterol in alcoholics with liver disease.

Matas C, Cabré M, La Ville A, Prats E, Joven J, Turner PR, Masana L, Camps J. Matas C, et al. Among authors: turner pr. Clin Chem. 1994 Mar;40(3):404-6. Clin Chem. 1994. PMID: 8131276

8

Toxicity of lovastatin in rats with experimentally induced nephrotic syndrome.

Joven J, Vilella E, Camps J, Masana L, Turner PR, Simó JM, Villabona C. Joven J, et al. Among authors: turner pr. Nephron. 1990;56(4):399-404. doi: 10.1159/000186183. Nephron. 1990. PMID: 2079999

9

Plasma lipoprotein alterations in patients with chronic hepatocellular liver disease resulting from alcohol abuse: effects of alcohol intake cessation.

Camps J, Pizarro I, Prats E, La Ville A, Turner PR, Masana L, Joven J. Camps J, et al. Among authors: turner pr. J Hepatol. 1994 Nov;21(5):704-9. doi: 10.1016/s0168-8278(94)80227-0. J Hepatol. 1994. PMID: 7890883

10

The Mediterranean-type diet: is there a need for further modification?

Masana L, Camprubi M, Sarda P, Sola R, Joven J, Turner PR. Masana L, et al. Among authors: turner pr. Am J Clin Nutr. 1991 Apr;53(4):886-9. doi: 10.1093/ajcn/53.4.886. Am J Clin Nutr. 1991. PMID: 2008868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters